48,836
edits
(→IHC) |
(→IHC) |
||
Line 686: | Line 686: | ||
Features:<ref name=pmid21602815/> | Features:<ref name=pmid21602815/> | ||
*CK7 +ve. | *CK7 +ve. | ||
** | **Usually -ve in clear cell RCC. | ||
*CD10 -ve. | *CD10 -ve. | ||
** | **Usually +ve in clear cell RCC. | ||
**Positive in Xp11.2 translocation carcinoma.<ref name=pmid21804394>{{Cite journal | last1 = He | first1 = H. | last2 = Zhou | first2 = GX. | last3 = Zhou | first3 = M. | last4 = Chen | first4 = L. | title = The distinction of clear cell carcinoma of the female genital tract, clear cell renal cell carcinoma, and translocation-associated renal cell carcinoma: an immunohistochemical study using tissue microarray. | journal = Int J Gynecol Pathol | volume = 30 | issue = 5 | pages = 425-30 | month = Sep | year = 2011 | doi = 10.1097/PGP.0b013e318214dd4f | PMID = 21804394 }}</ref> | |||
*TFE3 -ve. | *TFE3 -ve. | ||
**By definition +ve in [[Xp11.2 translocation carcinoma]]. | **By definition +ve in [[Xp11.2 translocation carcinoma]]. |
edits